✓ Last verified: April 22, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
Known For: Harvard-affiliated academic medical center ketamine program — the gold standard in clinical research and evidence-based ketamine treatment.
| Review Scores | Harvard-affiliated academic medical center; leading ketamine research institution |
| Location | Boston, MA |
| Address | Wang Building, Massachusetts General Hospital, Boston, MA 02114 |
| Phone | (617) 724-5510 |
| Website | massgeneral.org |
| Treatments | IV Ketamine, Esketamine (Intranasal) |
| Conditions Treated | Treatment-Resistant Depression, Major Depressive Disorder |
| Cost | Contact clinic for pricing |
| Insurance | Contact clinic; esketamine may be covered by insurance |
| Clinical Lead | Dr. Cristina Cusin, MD |
💡 No clinic-specific pricing posted? See our ketamine therapy cost guide for typical pricing ranges by treatment type and insurance pathways.
HealingMaps Take: Mass General Hospital’s IV Ketamine Clinic represents the apex of evidence-based ketamine treatment in Boston — and arguably in the entire country. Led by Dr. Cristina Cusin, MD, the program operates within the research and clinical infrastructure of Massachusetts General Hospital, Harvard Medical School’s largest teaching hospital. This is not a standalone infusion clinic; it is an academic medical center program backed by decades of institutional expertise in psychiatry, anesthesiology, and clinical research. For patients who prioritize clinical rigor, safety infrastructure, and access to the latest research protocols, MGH is the definitive choice. The clinic offers both IV ketamine and intranasal esketamine, and the hospital setting provides a level of emergency response capability that no outpatient clinic can match.
Market Position: Mass General Hospital IV Ketamine Clinic is a Spravato-certified clinic in the Boston metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
Industry pricing reference. Mass General Hospital IV Ketamine Clinic has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | ✓ Yes |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Suffolk County, MA, crude prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
Even Spravato copays are HSA and FSA-eligible — meaning the $0–$250 per-session cost that commercial insurance leaves you can often be paid with pre-tax dollars, reducing the effective out-of-pocket by your marginal tax rate. Ask your Spravato-certified provider to document the treatment as medically necessary for your records. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
This 3-question summary is matched to the protocols and conditions Mass General Hospital IV Ketamine Clinic treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Mass General Hospital IV Ketamine Clinic offers Spravato and IV ketamine — a 2-protocol practice. Patients can switch between or combine modalities without changing providers. Confirm specific dosing schedules and which protocols are recommended for your condition during your consult.
Yes — Mass General Hospital IV Ketamine Clinic offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Mass General Hospital IV Ketamine Clinic treats depression via Spravato (FDA-approved for TRD), and IV ketamine (off-label, evidence-based). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Learn more about the evidence behind ketamine for depression at the National Institute of Mental Health.
Leave a Reply